Ulcerative Colitis (UC)
129
49
55
28
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
3.1%
4 terminated out of 129 trials
87.5%
+1.0% vs benchmark
9%
11 trials in Phase 3/4
36%
10 of 28 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 28 completed trials
Clinical Trials (129)
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Impact of BAFF Gene Polymorphisms on the Risk of Ulcerative Colitis and the Efficacy of Vedolizumab.
the REMONO-CD and the REMONO-UC Studies
Evaluate the Safety, Tolerability, PK and PD of SAD of Intravenously Adminsterted ALTB-268 in Healthy Participants
Uneven Nutrition and Life Style as IBD Triggers in Adolescents and Adults
Efficacy and Safety of Vedolizumab Combined With Upadacitinib in Patients With Ulcerative Colitis
Multi-omics Dissection of Gut Microbiome Engraftment During FMT
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Ketogenic and Carnivore (Lion) Diets for Inflammatory Bowel Disease and Rheumatoid Arthritis
Immunosuppressant Discontinuation in Elderly Patients With Ulcerative Colitis And Long-term Remission
A Study of MB-001 in Moderately to Severely Active Ulcerative Colitis
Effectiveness of Ozanimod in Patients With Steroid-Dependent Ulcerative Colitis
The Purpose of This Study is to Evaluate the Efficacy and Safety of 627 in the Treatment of UC
Selenium Supplementation in Moderate-Severely Active Ulcerative Colitis Patients Treated With Advanced Therapies
Prospective Evaluation of the Carbon Footprint and Clinical Utility of IBUS Compared to Colonoscopy and Enterography in UC and CD
Zymfentra (Infliximab-dyyb) REal World Cohort STudy
Effectiveness and Safety of Upadacitinib for Acute Severe Ulcerative Colitis
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Impact Of The Gut Microbiota On Host Cells Energy Metabolism in Health And In Inflammatory Bowel Disease
An Observational Study to Learn About Velsipity After Long Term Use in Patients With Ulcerative Colitis